
News|Articles|July 1, 2006
Salmeterol/fluticasone combination lowers asthma exacerbations
A salmeterol/fluticasone combination (SFC) surpassed a formoterol/budesonide combination (FBC) in reducing the rate of moderate-to-severe exacerbations in patients with persistent asthma, according to a study published by the journal Respiratory Medicine.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Patient-facing EHR tool improves lung cancer screening identification
2
How California is rewriting the PBM playbook
3
Study highlights high costs, treatment challenges for older adults with HER2-positive advanced gastric cancer
4
Children’s Hospital of Philadelphia and Soar Autism Center launch early autism care network
5





















































